Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
18.1M
-
Shares change
-
+230K
-
Total reported value, excl. options
-
$181M
-
Value change
-
+$1.49M
-
Number of buys
-
21
-
Number of sells
-
-24
-
Price
-
$10.00
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q4 2018
58 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q4 2018.
Replimune Group, Inc. - COMMON STOCK (REPL) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.1M shares
of 78.4M outstanding shares and own 23.15% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.1M shares), Bain Capital Life Sciences Investors, LLC (2.84M shares), Redmile Group, LLC (2.19M shares), Foresite Capital Management IV, LLC (1.23M shares), BVF INC/IL (900K shares), Foresite Capital Management III, LLC (780K shares), BlackRock Inc. (716K shares), EMERALD ADVISERS, LLC (651K shares), EMERALD MUTUAL FUND ADVISERS TRUST (626K shares), and FMR LLC (474K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.